Further, sustained decrease in testosterone levels along with the downregulated steroidogenesis genes (GATA6 and GATA1) indicate a long-term impact on LC function and aligns well with clinical data showing decreased testosterone levels in COVID-19 patients for up to 7 months after recovery [18,54,55]. The gene discussed is GATA6; the disease is COVID-19.